Event Listings

Smart Energy International is the smart energy industry’s platform to the future. The event will focus on integration strategies for all the different components of the smart energy ecosystem. Featuring three key tracks on Energy Sustainability, Operations Excellence and Customer Engagement, the event will deliver insights from local and international utilities, government agencies and leading technology vendors.

C5 has designed the IQ Intensive programme to give you a sophisticated and comprehensive understanding of the issues facing the pharmaceutical industry from EU regulation. The programme will give a thorough training for Life Sciences lawyers and Regulatory Affairs professionals in the crucial regulatory competencies needed to work within the protocols of the European Medicines Agency (the EMA) and other bodies responsible for regulation of the pharmaceutical industry.

 

Healthcare reform has ushered in a new round of M&A activity in the provider market. A new and more energetic deal making environment is being driven by legislation enabling tens of millions of previously uninsured individuals to seek health services, by mandated IT infrastructure investments and by a strengthening economy and credit market.

However, given the many uncertainties such significant changes in the business landscape bring, the full contours of this new healthcare world are still revealing themselves. Many questions remain: What should providers do to position themselves for the full impact of healthcare reform? What geographic locations will experience increased demand for providers? Which market segments lack the economies of scale required for success? What terms and conditions will be available in the finance markets?

The 3rd Annual Healthcare Deal Making Summit – acknowledged as the industry standard forum for intelligence gathering and relationship building – is specifically designed to empower healthcare dealmakers with the latest expert analysis and the best opportunities to network with fellow executives. Leading players representing healthcare providers, private equity investors, commercial lenders, investment bankers and Washington insiders will come together to share their perspectives, gain market insight and develop the relationships that lead to deals.

Renowned for offering attendees the opportunity to hear from the highest level of speakers, the Healthcare Deal Making Summit will again represent the forefront of the market intelligence and the best chance to network with the people you need to make deals happen.

We are delighted to announce the launch of Market Access World USA, the world’s most comprehensive policy forum. This conference follows a highly successful series of market access events and will focus on US reform against an international backdrop. Speakers include Simon Stevens, President, Global Health and Executive VP, UnitedHealth Group, Michael Lauer MD, Director, Division of Cardiovascular Sciences, NIH, Jean R. Slutsky, Director, Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, Prof Sir Michael Rawlins, Chairman, NICE, Patrick Conway, MD, MSc, CMO, OS/ASPE, Dept. of Health and Human Services and more.

As healthcare becomes prime focus in the MENA region, this 2-day international event presents itself as an unprecedented business development opportunity for every company with its core business dedicated to healthcare infrastructure, hospital construction, private equity, legal, regulatory issues and latest cutting edge IT and medical equipment solutions.

 

The Summit will bring together interested companies, financial institutions and government representatives with financeable healthcare projects and will explore the critical issues for successful development and structuring of PPPs and private equity healthcare infrastructure investments across the region.

 

SMi's 16th annual European Pharmaceutical Pricing and Reimbursement Conference will look at vital P&R issues relating to market access, health technology assessment, risk management and competition law. Attendees will be shown how to develop a comprehensive pricing and reimbursement strategy which focuses on efficiency, value and transparency.

Key conference topics:
• Country-specific updates on pricing policies within selected EU member states
• Market access, brand planning and patient access
• Key provisions of the EU Transparency Directive
• Health technology assessment and Outcomes research
• Regional stakeholder relationships
• Reimbursement schemes and risk sharing agreements

PLUS an associated pre-conference workshop:

Economic Evaluations in Clinical Trials - Strategy, Design, Opportunities and Pitfalls Led by Klaus Hieke of NEOS Health, 26th July, 1.00pm to 5.00pm, Hilton Munich City Hotel

 

LogiPharma Asia examines the top logistics issues and challenges of the pharmaceutical industry in Asia. Logipharma Asia is attended by over 250 delegates, with 65% of the audience coming from the pharmaceutical (manufacturing) industry.

Key topics of the event include:
• Overcoming the differences to achieve temperature controlled (cold chain) distribution
• Understanding how your supply chain remain efficient despite the increasing labour and energy cost
• Managing costs and reducing expenditure across the supply chain
• Examining the unique distribution infrastructure
• Achieving medicine quality in last mile supply chain
• Maintaining an agile and responsive supply chain at greater distances
• Working collaboratively with outsourced companies to ensure maximum benefits and efficiencies
• Ensuring accurate forecasting and demand planning to minimise inventory
• Examining key clinical trial’s supply chain challenges
For more information, please contact wbrinfo@wbresearch.com